Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    18997198 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Cilostazol;   Drug: Acetylsalicylic acid
2 Completed Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial
Conditions: Coronary Disease;   Arteriosclerosis;   Diabetes Mellitus, Type 2
Interventions: Drug: Aspirin;   Drug: No aspirin

Indicates status has not been verified in more than two years